연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2023년 | 2022년 | 2021년 | 2020년 | 2019년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 173편 | 163편 | 184편 | 135편 | 144편 |
| 공동 | 120편 | 115편 | 136편 | 168편 | 167편 | |
| 합계 | 293편 | 278편 | 320편 | 303편 | 311편 | |
2261. Early closure of a Phase I clinical trial for SABR in early-stage glottic cancer
Kang BH, Yu T, Kim JH, Park JM, Kim JI, Chung EJ, Kwon SK, Kim JH, Wu HG
Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):104-109
Link
2260. MicroRNA-17 acts as a tumor chemosensitizer by targeting JAB1/CSN5 in triple-negative breast cancer.
Wang S1, Oh DY2, Leventaki V3, Drakos E4, Zhang R5, Sahin AA6, Resetkova E6, Edgerton ME6, Wu W7, Claret FX8.
Cancer Lett. 2019 Nov 28;465:12-23. doi: 10.1016/j.canlet.2019.08.016. Epub 2019 Aug 29.
Link
2259. ATM in DNA repair in cancer.
Jin MH1, Oh DY2.
Pharmacol Ther. 2019 Nov;203:107391. doi: 10.1016/j.pharmthera.2019.07.002. Epub 2019 Jul 9.
Link
2258. GC1118, a novel anti-EGFR antibody, has potent KRAS mutation-independent antitumor activity compared with cetuximab in gastric cancer.
Park JE1, Jin MH1, Hur M2, Nam AR1, Bang JH1, Won J2, Oh DY3,4, Bang YJ1,5.
Gastric Cancer. 2019 Sep;22(5):932-940. doi: 10.1007/s10120-019-00943-x. Epub 2019 Feb 27.
Link
2257. Enhanced antitumor effect of binimetinib in combination with capecitabine for biliary tract cancer patients with mutations in the RAS/RAF/MEK/ERK pathway: phase Ib study.
Kim JW1, Lee KH2,3, Kim JW1, Suh KJ1, Nam AR3, Bang JH3, Bang YJ2,3, Oh DY4,5.
Br J Cancer. 2019 Aug;121(4):332-339. doi: 10.1038/s41416-019-0523-5. Epub 2019 Jul 17.
Link
2256. Prognostic implications of soluble programmed death-ligand 1 and its dynamics during chemotherapy in unresectable pancreatic cancer.
Park H1, Bang JH2, Nam AR2, Eun Park J2, Hua Jin M2, Bang YJ1,2, Oh DY3,4.
Sci Rep. 2019 Jul 31;9(1):11131. doi: 10.1038/s41598-019-47330-1.
Link
2255. Therapeutic Co-targeting of WEE1 and ATM Downregulates PD-L1 Expression in Pancreatic Cancer.
Jin MH1, Nam AR1, Park JE1, Bang JH1, Bang YJ1,2, Oh DY1,2.
Cancer Res Treat. 2019 Jun 25. doi: 10.4143/crt.2019.183.
Link
2254. Pylorus-preserving gastrectomy for early cancer involving the upper third: can we go higher?
Zhu CC1,2, Cao H2, Berlth F1,3, Xu J2, Park SH1, Choe HN1, Suh YS1, Kong SH1, Lee HJ1,4, Kim WH5, Yang HK6,7.
Gastric Cancer. 2019 Jul;22(4):881-891. doi: 10.1007/s10120-018-00921-9. Epub 2019 Feb 19.
Link
2253. Evaluation of the feasibility and preference of Nox-A1 type 2 ambulatory device for unattended home sleep test: a randomized crossover study
Dae Wui Yoon1 · Il‑Hee Hong2 · Inkyung Baik3 · Hyun‑Woo Shin1,4,5,6
Sleep and Biological Rhythms.July 2019,Volume 17, Issue 3, pp 297–304
2252. The IFN-γ-p38, ERK kinase axis exacerbates neutrophilic chronic rhinosinusitis by inducing the epithelial-to-mesenchymal transition.
Lee M1,2,3, Kim DW4, Khalmuratova R1, Shin SH2,3, Kim YM5, Han DH6, Kim HJ6, Kim DY6, Rhee CS7, Park JW1,2,3,8, Shin HW9,10,11,12,13.
Mucosal Immunol. 2019 May;12(3):601-611. doi: 10.1038/s41385-019-0149-1. Epub 2019 Feb 25.
Link